Severe Hypoglycemia Due to Prolonged Insulin Effect and Reduced Renal Clearance
This patient developed severe hypoglycemia (BG 34 mg/dL) primarily due to impaired insulin clearance from chronic kidney disease combined with the prolonged action of NPH insulin and an inappropriate correction dose given during declining blood glucose levels.
What Happened: Step-by-Step Analysis
1. Impaired Insulin Clearance (Primary Factor)
The patient has chronic renal disease (Cr 1.16, GFR 87 mL/min) which significantly affects insulin metabolism. The kidneys normally remove and degrade 6-8 units of insulin per 24 hours, with renal extraction of approximately 200 mL/min 1. With reduced kidney function, insulin clearance decreases substantially, leading to prolonged insulin action and accumulation 2, 3.
- In patients with renal impairment, insulin requirements can decrease by up to 50% 3
- The 44 units of NPH given at 8 pm was likely excessive for this patient's reduced renal clearance
- NPH insulin has a peak action of 4-12 hours and duration of up to 24 hours 4
2. Inappropriate Correction Dose
At 10 am, the patient received 2 units of correction insulin when BG was 199 mg/dL. This was a critical error because:
- The blood glucose was already declining (246 at 0330 → 199 at 0800)
- The NPH from 8 pm was still active (within its 24-hour duration window)
- Adding rapid-acting insulin on top of active basal insulin created insulin stacking
- The correction dose was given only 1.5 hours before the hypoglycemic event
3. Linezolid Contribution (Possible)
Linezolid was started at 8 pm and given again at 8 am. While the FDA label does not specifically list hypoglycemia as a direct effect 5, linezolid is a reversible, nonselective monoamine oxidase inhibitor which can potentially affect glucose metabolism. However, this is likely a minor contributing factor compared to the insulin-related issues.
4. Tube Feeding Timing
The tube feeding (224g CHO) ran from 8 pm to 8 am, providing continuous carbohydrate. After tube feeding stopped at 8 am, there was no ongoing carbohydrate source, but insulin action continued 6. The guidelines recommend that when enteral nutrition is interrupted, 10% dextrose infusion should be started immediately to prevent hypoglycemia 6.
Key Pathophysiologic Mechanisms
In chronic kidney disease, several factors converge to increase hypoglycemia risk:
- Impaired insulin degradation (normally 30-45% renal extraction) 1
- Decreased gluconeogenesis capacity
- Reduced clearance of insulin metabolites 7
- Hypoglycemia in ESRD patients accounts for up to 3.6% of admissions with 30% mortality when occurring during hospitalization 3
Critical Management Errors
- Excessive NPH dose for patient's renal function (should have been reduced by 25-50%)
- Correction insulin given during declining glucose trend without considering active basal insulin
- No dextrose infusion started when tube feeding discontinued at 8 am 6
- Inadequate glucose monitoring - should have been checked 2-4 hours after tube feeding stopped 6
Prevention Strategy
For patients with CKD (GFR <90) receiving NPH and tube feedings:
- Reduce NPH dose by 25-50% from standard calculations 2, 3
- Never give correction insulin when BG is declining - wait to see the trend
- Start 10% dextrose at 50 mL/hr immediately when tube feeding stops 8
- Monitor BG every 2-4 hours during and after tube feeding 6
- Consider switching from NPH to long-acting analog (less hypoglycemia risk) 9
- In renal impairment, insulin requirements decrease as kidney disease progresses 2
Common Pitfall
The most dangerous error was giving correction insulin at 10 am without recognizing that the patient's glucose was already falling and NPH was still active. This represents "insulin stacking" - adding rapid-acting insulin on top of active basal insulin. In patients with reduced renal clearance, this effect is magnified and prolonged, leading to severe hypoglycemia hours later 4, 3.